It promises cures for diseases, sturdier crops, malaria - resistant mosquitoes and more.
Not exact matches
In September, CZI committed $ 3 billion to help fund
cures for all the
diseases facing humanity by 2100 as part of Zuckerberg's
promise to donate 99 percent of his Facebook shares (a $ 45 billion - value in September 2015 when he announced the pledge).
The memory - eating
disease, expected to afflict 15 million Americans by 2060 (and tens of millions more around the world as life expectancy increases), has no
cure; a new drug
for the condition hasn't been approved in well over a decade; initially
promising experimental treatments seem to be failing with clockwork regularity; and there's not even a definitive consensus on what, exactly, biopharma companies should focus on while developing Alzheimer's medicines.
By accelerating
promising drug candidates through the drug discovery and development pipeline and spearheading innovative public - private partnerships, we increase the chance of finding an effective treatment, and a
cure,
for Alzheimer's
disease.
Senator Bernie Sanders (I — VT) has said he believes stem - cell research «represents an exciting and
promising line of research that could provide treatments and
cures for many debilitating
diseases.»
But that outlay
for dementia research falls well short of those announced in recent years by the United States and the United Kingdom and even lags Canada's
promise at the G8 dementia summit 2 years ago in London to significantly ramp up its investment in research on neurodegenerative
diseases as part of a global bid to find a
cure for dementia by 2025.
Italy is already beginning to show its
promise with the development of gene - therapy techniques and the discovery of genes that could lead to a
cure for Parkinson's
disease and other neurodegenerative disorders.
In humans, it holds the
promise of
curing genetic
disease, while in other organisms it provides methods to reshape the biosphere
for the benefit of the environment and human societies.
However, since the novel genes that were identified, are known to lead to aging - associated
diseases in humans, their further analysis seems to be
promising for developing new approaches to understand and possibly
cure these
diseases and to contribute to a long life and healthy aging in humans — in a way, long - lived rodents do.
One of the most
promising avenues
for developing a
cure, however, is through gene therapy, and to create those therapies requires animal models of
disease that closely replicate the human condition.
As a new generation of gene therapy clinical trials shows
promise to
cure or halt the progression of several rare
diseases, the time has come to explore ways to pay
for the cutting edge treatments, a pediatric hematologist - oncologist from Dana - Farber / Boston Children's Cancer and Blood Disorders Center argues in a commentary published by the journal Science.
That means thousands of
promising proposals that could lead to
cures for disease are not pursued every year.
The Rockefeller meeting may have been a downer
for patient advocacy groups that have been holding up rosy
promises of
cures for intractable
diseases including Parkinson's, Alzheimer's, and diabetes.
Diabetes has long been one of the main
diseases for which human embryonic stem cell (embryo - destroying) research, or hESCR, was claimed to hold the greatest
promise of
curing.
However, even though the results are
promising, scientists point out that a lot more testing and research is required to produce a
cure for the
disease.
The
promise of new CRISPR gene - editing technology has always been that it might lead to a
cure for specific genetic
diseases.
As medical research and healthcare is becoming ever more personalised and precise, the possibility to detect and
cure disease at an individual level offers unparalleled
promise for patients.
You know the story: a mercenary -
for - hire falls in love with an escort who eventually becomes his fiancée but it's derailed of a
promised storybook ending when the cancer is eating up 3/4 of his body, so he decides the only option he has
for his story tale ending is to undergo a radical experimental procedure that can
cure him of his
disease.